- 2012 HCPCS S2107
- Adoptive immunotherapy i.e. development of specific anti-tumor reactivity (e.g. tumor-infiltrating lymphocyte therapy) per course of treatment
- This is the 2012 version of HCPCS S2107 - please refer to the 2016 HCPCS code set for the latest version.
- Added on Monday, April 01, 2002
- Status changed on Monday, April 01, 2002 to: No maintenance for this code
- BETOS Classification: Undefined Codes
- Medicare coverage status: Not payable by Medicare (no grace period)
S2103 S2112 
